ABL Bio Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	33,403	65,547	67,301	5,332
Other Revenue	-0	0	-0	0
Revenue	33,403	65,547	67,301	5,332
Revenue Growth (YoY)	-49.04%	-2.61%	1162.19%	-
Cost of Revenue	61.26	46.25	83.76	47.98
Gross Profit	33,342	65,501	67,217	5,284
Selling, General & Admin	16,231	13,493	15,569	13,962
Research & Development	74,079	52,035	48,416	41,034
Operating Expenses	92,719	68,118	66,309	56,472
Operating Income	-59,377	-2,617	908	-51,188
Interest Expense	-36.04	-2,151	-1,326	-41.98
Interest & Investment Income	1,877	1,294	233.75	99.72
Currency Exchange Gain (Loss)	1,373	734.04	1,761	864.43
Other Non Operating Income (Expenses)	249.56	-1,037	2,176	47.62
EBT Excluding Unusual Items	-55,914	-3,776	3,753	-50,218
Gain (Loss) on Sale of Investments	391.27	1,132	-592.13	6,666
Gain (Loss) on Sale of Assets	-7.03	-2.64	48	-5.83
Pretax Income	-55,529	-2,647	3,209	-43,558
Net Income	-55,529	-2,647	3,209	-43,558
Net Income to Common	-55,529	-2,647	3,209	-43,558
Shares Outstanding (Basic)	48	48	48	47
Shares Outstanding (Diluted)	48	48	48	47
Shares Change (YoY)	0.37%	0.58%	1.27%	-
EPS (Basic)	-1156.34	-55.32	67.46	-927.36
EPS (Diluted)	-1156.34	-55.32	67.46	-927.36
Free Cash Flow	-78,426	-34,102	70,076	-41,850
Free Cash Flow Per Share	-1633.14	-712.77	1473.23	-890.99
Gross Margin	99.82%	99.93%	99.88%	99.10%
Operating Margin	-177.76%	-3.99%	1.35%	-959.99%
Profit Margin	-166.24%	-4.04%	4.77%	-816.91%
Free Cash Flow Margin	-234.79%	-52.03%	104.12%	-784.87%
EBITDA	-56,967	-27.32	3,233	-49,029
EBITDA Margin	-170.55%	-0.04%	4.80%	-
D&A For EBITDA	2,410	2,590	2,325	2,158
EBIT	-59,377	-2,617	908	-51,188
EBIT Margin	-177.76%	-3.99%	1.35%	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.